Table 1.
Baseline characteristics of children enrolled in the study of efficacy and safety of EcN for immunity improvement in late preterm newborns
| Characteristics | EcN (N = 30) | Control (N = 32) | |
|---|---|---|---|
| Gestational age at birth (weeks) | 35.5 ± 0.5 | 35.5 ± 0.5 | |
| Age at inclusion (hours) | 17.3 ± 3.8 | 17.4 ± 3.3 | |
| Sex | Female | 14 (46.7) | 15 (46.9) |
| Male | 16 (53.3) | 17 (53.1) | |
| Type of birth | Vaginal | 28 (93.3) | 26 (81.3) |
| Caesarean | 2 (6.7) | 6 (18.8) | |
| Birth weight (g) | 2400 ± 122 | 2396 ± 77 | |
| Birth length (cm) | 45.2 ± 0.8 | 45.2 ± 0.9 | |
| APGAR scores | I | 7.5 ± 0.5 | 7.6 ± 0.6 |
| II | 8.1 ± 0.3 | 8.1 ± 0.3 | |
Data are mean ± SD or number (%)
SD standard deviation, APGAR score Appearance, Pulse, Grimace, Activity, Respiration score